Reversible sideroblastic anemia caused by pyrazinoic acid (Pyrazinamide).
D000328:Adult; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000740:Anemia / Q000209:etiology*; D000756:Anemia, Sideroblastic / Q000209:etiology; D004920:Erythropoiesis / Q000187:drug effects; D005000:Ethionamide / Q000627:therapeutic use; D005260:Female; D005494:Folic Acid Deficiency / Q000188:drug therapy*; D005955:Glucosephosphate Dehydrogenase Deficiency; D006801:Humans; D066298:In Vitro Techniques; D007538:Isoniazid / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011718:Pyrazinamide / Q000009:adverse effects*; D011736:Pyridoxine / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D014805:Vitamin B 12 / Q000627:therapeutic use
D000636:Aminosalicylic Acids; D011718:Pyrazinamide; D011239:Prednisolone; D011736:Pyridoxine; D005000:Ethionamide; D014805:Vitamin B 12; D007538:Isoniazid; D013307:Streptomycin